Chris Williams focuses his practice on antitrust issues related to commercial transactions, including mergers and acquisitions (M&A); joint ventures and other strategic collaborations; licensing of intellectual property; and pricing, supply, and distribution agreements. His experience includes cross-border matters involving regulatory authorities in China, Japan, South Korea, and Europe.

Chris advises on all aspects of merger control, including evaluating regulatory clearance; advising on transaction structure and antitrust risk allocation in M&A agreements; preparing phases of merger notification filings, including under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act); advocating for clients in Second Request investigations by the U.S. Department of Justice (DOJ) and the Federal Trade Commission (FTC); directing strategy in merger reviews by foreign competition authorities; advising on remedy proposals and negotiations; representing interested third parties and divestiture buyers; and providing guidance on diligence, integration planning, and other pre-closing matters.